PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
116 hedge funds and large institutions have $130M invested in PhenomeX Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 14 closing their positions.
338% more call options, than puts
Call options by funds: $149K | Put options by funds: $34K
43% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 14
33% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 33
3% more funds holding
Funds holding: 113 → 116 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less capital invested
Capital invested by funds: $138M → $130M (-$8.24M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Monaco Asset Management
Monaco
|
+$3.67M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.51M |
| 3 |
NIMC
Nierenberg Investment Management Company
Camas,
Washington
|
+$2.89M |
| 4 |
Millennium Management
New York
|
+$2.77M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$7.13M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$6.25M |
| 3 |
Morgan Stanley
New York
|
-$2.54M |
| 4 |
BlackRock
New York
|
-$823K |
| 5 |
Lazard Asset Management
New York
|
-$668K |
CELL Hedge Fund Activity: Q4 2022 in Review
116 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q4 2022, worth a combined $130M — down 6% from $138M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new CELL positions and 14 closed out — a net gain of 6 holders — while 44 added to existing stakes and 33 trimmed.
The largest buyer was Monaco Asset Management, adding an estimated $3.67M. The largest seller was ARK Investment Management, cutting an estimated $7.13M.
- 116 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q4 2022, up from 113 in Q3 2022.
- Funds reported $130M of PhenomeX Inc. Common Stock stock for Q4 2022, down 6% quarter-over-quarter.
- 20 funds opened new PhenomeX Inc. Common Stock positions in Q4 2022 and 14 closed out, a net change of +6 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q4 2022 was Monaco Asset Management, an estimated $3.67M added.
- The largest PhenomeX Inc. Common Stock seller in Q4 2022 was ARK Investment Management, an estimated $7.13M sold.
Based on aggregated 13F filings for Q4 2022.